Crossmark

Resolving mechanisms of immune‐mediated disease in primary <scp>CD</scp> 4 T cells

Crossref DOI link: https://doi.org/10.15252/emmm.202012112

Published Online: 2020-04

Published Print: 2020-05-08

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Bourges, Christophe

Groff, Abigail F

Burren, Oliver S

Gerhardinger, Chiara

Mattioli, Kaia

Hutchinson, Anna

Hu, Theodore

Anand, Tanmay

Epping, Madeline W

Wallace, Chris

Smith, Kenneth GC

Rinn, John L https://orcid.org/0000-0002-7231-7539
Lee, James C https://orcid.org/0000-0001-5711-9385
Funding

Funding for this research was provided by:

Wellcome Trust (105920/Z/14/Z, WT107881)

Crohn's and Colitis UK (M2018/3)

Howard Hughes Medical Institute

Engineering and Physical Sciences Research Council (EP/R511870/1)

Medical Research Council (MC UU 00002/4)

National Institute for Health Research

GlaxoSmithKline
License Information

Version of Record valid from 2020-04-01
More Information

Publication History

Received: 2020-02-01

Accepted: 2020-03-09

Published: 2020-04-01